Aeterna Zentaris
AEZS
#10800
Rank
โ‚น1.64 B
Marketcap
โ‚น537.13
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2023 (TTM): -โ‚น383.78

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -โ‚น192.40. In 2022 the company made an earnings per share (EPS) of -โ‚น438.53 a decrease over its 2021 EPS that were of -โ‚น184.05.

EPS history for Aeterna Zentaris from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น383.78-12.48%
2022-โ‚น438.53138.27%
2021-โ‚น184.05-48.05%
2020-โ‚น354.29-56.88%
2019-โ‚น821.65-240%
2018โ‚น586.89-122.94%
2017-โ‚น2,559-54.96%
2016-โ‚น5,681-93.07%
2015-โ‚น81,95120.13%
2014-โ‚น68,221-225.69%
2013โ‚น54,276-122.24%
2012-โ‚น2,44,101-42.55%
2011-โ‚น4,24,911-12.98%
2010-โ‚น4,88,296-17.46%
2009-โ‚น5,91,588-62.5%
2008-โ‚น15,77,56783.66%
2007-โ‚น8,58,958-227.16%
2006โ‚น6,75,511105.81%
2005โ‚น3,28,223-334.56%
2004-โ‚น1,39,931-79.94%
2003-โ‚น6,97,65313.5%
2002-โ‚น6,14,687604.55%
2001-โ‚น87,245-84.33%
2000-โ‚น5,56,893275.3%
1999-โ‚น1,48,385

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น492.99-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น178.69-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น424.44-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.81-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น330.54-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA